RU2012127810A - Крупномасштабное получение функциональных мегакариоцитов и тромбоцитов из человеческих эмбриональных стволовых клеток в бесстромальных условиях - Google Patents
Крупномасштабное получение функциональных мегакариоцитов и тромбоцитов из человеческих эмбриональных стволовых клеток в бесстромальных условиях Download PDFInfo
- Publication number
- RU2012127810A RU2012127810A RU2012127810/10A RU2012127810A RU2012127810A RU 2012127810 A RU2012127810 A RU 2012127810A RU 2012127810/10 A RU2012127810/10 A RU 2012127810/10A RU 2012127810 A RU2012127810 A RU 2012127810A RU 2012127810 A RU2012127810 A RU 2012127810A
- Authority
- RU
- Russia
- Prior art keywords
- stem cells
- tpo
- pluripotent stem
- concentration
- medium
- Prior art date
Links
- 210000000130 stem cell Anatomy 0.000 title claims 2
- 238000011031 large-scale manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract 66
- 210000003593 megakaryocyte Anatomy 0.000 claims abstract 26
- 210000001778 pluripotent stem cell Anatomy 0.000 claims abstract 21
- 210000003566 hemangioblast Anatomy 0.000 claims abstract 20
- 102000004127 Cytokines Human genes 0.000 claims abstract 14
- 108090000695 Cytokines Proteins 0.000 claims abstract 14
- 230000004069 differentiation Effects 0.000 claims abstract 14
- 239000003102 growth factor Substances 0.000 claims abstract 14
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 claims abstract 12
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims abstract 12
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims abstract 12
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims abstract 12
- 102100020715 Fms-related tyrosine kinase 3 ligand protein Human genes 0.000 claims abstract 9
- 101710162577 Fms-related tyrosine kinase 3 ligand protein Proteins 0.000 claims abstract 9
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims abstract 8
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims abstract 7
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims abstract 7
- 238000010494 dissociation reaction Methods 0.000 claims abstract 7
- 230000005593 dissociations Effects 0.000 claims abstract 7
- 238000000338 in vitro Methods 0.000 claims abstract 7
- 239000000126 substance Substances 0.000 claims abstract 7
- 102100020880 Kit ligand Human genes 0.000 claims abstract 6
- 101710177504 Kit ligand Proteins 0.000 claims abstract 6
- 102100027188 Thyroid peroxidase Human genes 0.000 claims abstract 6
- 101710113649 Thyroid peroxidase Proteins 0.000 claims abstract 6
- 235000015097 nutrients Nutrition 0.000 claims abstract 6
- 230000015572 biosynthetic process Effects 0.000 claims abstract 3
- 238000012258 culturing Methods 0.000 claims abstract 3
- 210000002242 embryoid body Anatomy 0.000 claims abstract 3
- 210000001671 embryonic stem cell Anatomy 0.000 claims abstract 2
- 239000002609 medium Substances 0.000 claims 29
- 102000003815 Interleukin-11 Human genes 0.000 claims 11
- 108090000177 Interleukin-11 Proteins 0.000 claims 11
- 210000001082 somatic cell Anatomy 0.000 claims 6
- 229920000669 heparin Polymers 0.000 claims 5
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims 5
- 230000024245 cell differentiation Effects 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims 2
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 claims 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 2
- 102000026633 IL6 Human genes 0.000 claims 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 2
- 229930003537 Vitamin B3 Natural products 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 229930182833 estradiol Natural products 0.000 claims 2
- 229960005309 estradiol Drugs 0.000 claims 2
- 210000003754 fetus Anatomy 0.000 claims 2
- 230000003394 haemopoietic effect Effects 0.000 claims 2
- 230000003343 megakaryocytopoietic effect Effects 0.000 claims 2
- 229960003512 nicotinic acid Drugs 0.000 claims 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 2
- 230000003022 thrombocytopoietic effect Effects 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- 239000011708 vitamin B3 Substances 0.000 claims 2
- 235000019160 vitamin B3 Nutrition 0.000 claims 2
- 102000007347 Apyrase Human genes 0.000 claims 1
- 108010007730 Apyrase Proteins 0.000 claims 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0644—Platelets; Megakaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/145—Thrombopoietin [TPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2311—Interleukin-11 (IL-11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/91—Heparin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1394—Bone marrow stromal cells; whole marrow
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26693909P | 2009-12-04 | 2009-12-04 | |
| US61/266,939 | 2009-12-04 | ||
| US38416510P | 2010-09-17 | 2010-09-17 | |
| US61/384,165 | 2010-09-17 | ||
| PCT/US2010/058990 WO2011069127A1 (en) | 2009-12-04 | 2010-12-03 | Large scale generation of functional megakaryocytes and platelets from human embryonic stem cells under stromal-free conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2012127810A true RU2012127810A (ru) | 2014-01-10 |
Family
ID=44115332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012127810/10A RU2012127810A (ru) | 2009-12-04 | 2010-12-03 | Крупномасштабное получение функциональных мегакариоцитов и тромбоцитов из человеческих эмбриональных стволовых клеток в бесстромальных условиях |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9988603B2 (enExample) |
| EP (1) | EP2507359A4 (enExample) |
| JP (4) | JP2013512676A (enExample) |
| KR (4) | KR20190142424A (enExample) |
| AU (4) | AU2010325811A1 (enExample) |
| BR (1) | BR112012013497A2 (enExample) |
| CA (2) | CA2782013C (enExample) |
| IN (1) | IN2012DN05054A (enExample) |
| RU (1) | RU2012127810A (enExample) |
| WO (1) | WO2011069127A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3712258B1 (en) | 2006-04-14 | 2025-01-01 | Astellas Institute for Regenerative Medicine | Hemangio-colony forming cells |
| KR20190142424A (ko) | 2009-12-04 | 2019-12-26 | 스템 셀 앤드 리제너러티브 메디신 인터내셔날, 인크. | 기질 없는 조건 하에서 인간 배아줄기세포로부터 기능적 거핵구 및 혈소판의 대규모 생성 |
| KR102108245B1 (ko) | 2011-11-30 | 2020-05-08 | 아스텔라스 인스티튜트 포 리제너러티브 메디슨 | 중간엽 간질 세포 및 이에 관련된 용도 |
| US8961956B2 (en) | 2011-11-30 | 2015-02-24 | Ocata Therapeutics, Inc. | Mesenchymal stromal cells and uses related thereto |
| GB201210857D0 (en) | 2012-06-19 | 2012-08-01 | Cambridge Entpr Ltd | Transcription factor mediated programming towards megakaryocytes |
| CN104471059B (zh) | 2012-07-12 | 2018-04-17 | 珠海横琴爱姆斯坦生物科技有限公司 | 人胚胎干细胞衍生的间充质样干细胞、方法及其应用 |
| US9074186B2 (en) | 2012-08-15 | 2015-07-07 | Boston Medical Center Corporation | Production of red blood cells and platelets from stem cells |
| EP3973967A1 (en) * | 2012-12-21 | 2022-03-30 | Astellas Institute for Regenerative Medicine | Methods for production of platelets from pluripotent stem cells and compositions thereof |
| JP6580329B2 (ja) | 2014-03-31 | 2019-09-25 | シスメックス株式会社 | 未分化細胞から分化細胞および／または分化細胞の産生物を取得する方法 |
| WO2015179301A1 (en) | 2014-05-19 | 2015-11-26 | Eleftherios Papoutsakis | Megakaryocytic particles and microparticles for cell therapy & fate modification of stem and progenitor cells |
| AU2016242823A1 (en) * | 2015-03-30 | 2017-09-21 | Jeffrey Thomas Loh | Methods for producing modified red blood cell compositions, compositions and uses thereof |
| AU2016308818B2 (en) | 2015-08-18 | 2022-04-21 | Astellas Institute For Regenerative Medicine | Clinical formulations |
| CN108135940B (zh) * | 2015-10-14 | 2022-04-15 | 株式会社美加细胞 | 纯化血小板的制造方法 |
| MX2020007071A (es) | 2018-01-05 | 2020-11-11 | Platelet Biogenesis Inc | Composiciones y metodos para producir megacariocitos. |
| WO2020006539A1 (en) | 2018-06-29 | 2020-01-02 | Platelet Biogenesis, Inc. | Compositions for drug delivery and methods of use thereof |
| CA3178268A1 (en) | 2020-05-11 | 2021-11-18 | Jonathan Thon | Compositions and methods related to megakaryocyte-derived extracellular vesicles |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5128259A (en) | 1989-10-27 | 1992-07-07 | Hahnemann University | Factor-dependent hematopoietic cell line exhibiting epo-induced erythrocyte maturation |
| EP1364197B1 (en) * | 2001-01-29 | 2010-04-14 | Ivan N. Rich | ATP-based assay for the determination of the proliferation status of hematopoietic stem and progenitor cells |
| WO2002078449A2 (en) | 2001-04-02 | 2002-10-10 | Advanced Cell Technology, Inc. | Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells |
| WO2003046141A2 (en) | 2001-11-26 | 2003-06-05 | Advanced Cell Technology, Inc. | Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| US20040052771A1 (en) | 2002-07-12 | 2004-03-18 | Lim Sai Kiang | Hemangioblast progenitor cells |
| US20040229350A1 (en) | 2003-05-12 | 2004-11-18 | Nikolai Strelchenko | Morula derived embryonic stem cells |
| CN1286970C (zh) | 2003-12-30 | 2006-11-29 | 上海伯瑞生物技术发展有限公司 | 由脐血cd34+细胞体外诱导生成巨核细胞的方法 |
| EP1735429A4 (en) | 2004-03-31 | 2008-06-11 | Newlink Genetics Corp | METHOD AND COMPOSITIONS FOR OBTAINING EMBRYONAL STEM CELLS OF ABSTINENT HEMATOPOETIC STEM CELLS AND USES THEREOF |
| WO2006050330A2 (en) * | 2004-11-01 | 2006-05-11 | Wisconsin Alumni Research Foundation | Platelets from stem cells |
| US7893315B2 (en) | 2004-11-04 | 2011-02-22 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells and embryo-derived cells |
| WO2007095064A2 (en) | 2006-02-09 | 2007-08-23 | Wisconsin Alumni Research Foundation | ERYTHROID CELLS PRODUCING ADULT-TYPE β-HEMOGLOBIN GENERATED FROM HUMAN EMBRYONIC STEM CELLS |
| CN101045914A (zh) | 2006-03-29 | 2007-10-03 | 中国人民解放军军事医学科学院野战输血研究所 | 体外诱导造血干/祖细胞分化为成熟红细胞的方法与应用 |
| EP3712258B1 (en) * | 2006-04-14 | 2025-01-01 | Astellas Institute for Regenerative Medicine | Hemangio-colony forming cells |
| JP2008307007A (ja) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
| US9683232B2 (en) * | 2007-12-10 | 2017-06-20 | Kyoto University | Efficient method for nuclear reprogramming |
| EP3441462A1 (en) | 2008-05-06 | 2019-02-13 | Astellas Institute for Regenerative Medicine | Hemangio colony forming cells and non-engrafting hemangio cells |
| CN112280739A (zh) | 2008-05-06 | 2021-01-29 | 安斯泰来再生医药协会 | 用于制备衍生自多能干细胞的去核类红细胞的方法 |
| KR20190142424A (ko) | 2009-12-04 | 2019-12-26 | 스템 셀 앤드 리제너러티브 메디신 인터내셔날, 인크. | 기질 없는 조건 하에서 인간 배아줄기세포로부터 기능적 거핵구 및 혈소판의 대규모 생성 |
-
2010
- 2010-12-03 KR KR1020197037186A patent/KR20190142424A/ko not_active Ceased
- 2010-12-03 IN IN5054DEN2012 patent/IN2012DN05054A/en unknown
- 2010-12-03 JP JP2012542230A patent/JP2013512676A/ja active Pending
- 2010-12-03 CA CA2782013A patent/CA2782013C/en active Active
- 2010-12-03 KR KR1020127017368A patent/KR20120128605A/ko not_active Ceased
- 2010-12-03 AU AU2010325811A patent/AU2010325811A1/en not_active Abandoned
- 2010-12-03 WO PCT/US2010/058990 patent/WO2011069127A1/en not_active Ceased
- 2010-12-03 BR BR112012013497A patent/BR112012013497A2/pt not_active Application Discontinuation
- 2010-12-03 KR KR1020217016080A patent/KR20210066020A/ko not_active Ceased
- 2010-12-03 EP EP10835231.1A patent/EP2507359A4/en not_active Withdrawn
- 2010-12-03 RU RU2012127810/10A patent/RU2012127810A/ru not_active Application Discontinuation
- 2010-12-03 CA CA3115233A patent/CA3115233A1/en not_active Abandoned
- 2010-12-03 US US13/512,827 patent/US9988603B2/en active Active
- 2010-12-03 KR KR1020187021160A patent/KR20180086301A/ko not_active Ceased
-
2016
- 2016-04-25 JP JP2016086761A patent/JP2016135138A/ja active Pending
-
2017
- 2017-03-24 AU AU2017201995A patent/AU2017201995B2/en not_active Ceased
-
2018
- 2018-05-01 US US15/968,591 patent/US20190002829A1/en not_active Abandoned
-
2019
- 2019-03-05 JP JP2019039160A patent/JP2019122385A/ja active Pending
- 2019-05-24 AU AU2019203670A patent/AU2019203670B2/en not_active Ceased
-
2022
- 2022-01-13 AU AU2022200188A patent/AU2022200188A1/en not_active Abandoned
- 2022-01-28 JP JP2022011675A patent/JP2022064953A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US9988603B2 (en) | 2018-06-05 |
| EP2507359A1 (en) | 2012-10-10 |
| JP2016135138A (ja) | 2016-07-28 |
| AU2017201995B2 (en) | 2019-06-06 |
| CA2782013A1 (en) | 2011-06-09 |
| US20120315338A1 (en) | 2012-12-13 |
| KR20180086301A (ko) | 2018-07-30 |
| KR20210066020A (ko) | 2021-06-04 |
| US20190002829A1 (en) | 2019-01-03 |
| AU2022200188A1 (en) | 2022-02-10 |
| IN2012DN05054A (enExample) | 2015-10-09 |
| WO2011069127A1 (en) | 2011-06-09 |
| KR20190142424A (ko) | 2019-12-26 |
| KR20120128605A (ko) | 2012-11-27 |
| AU2019203670B2 (en) | 2021-10-14 |
| JP2022064953A (ja) | 2022-04-26 |
| EP2507359A4 (en) | 2015-05-13 |
| CA3115233A1 (en) | 2011-06-09 |
| AU2010325811A1 (en) | 2012-06-21 |
| JP2013512676A (ja) | 2013-04-18 |
| AU2019203670A1 (en) | 2019-06-13 |
| BR112012013497A2 (pt) | 2016-05-31 |
| AU2017201995A1 (en) | 2017-04-13 |
| CA2782013C (en) | 2021-06-08 |
| JP2019122385A (ja) | 2019-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012127810A (ru) | Крупномасштабное получение функциональных мегакариоцитов и тромбоцитов из человеческих эмбриональных стволовых клеток в бесстромальных условиях | |
| US20220228118A1 (en) | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions | |
| JP6189581B2 (ja) | 幹細胞の分化のための方法および組成物 | |
| Tian et al. | Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells | |
| Hill et al. | Human embryonic stem cell− derived vascular progenitor cells capable of endothelial and smooth muscle cell function | |
| Wang et al. | Hematopoietic development from human embryonic stem cell lines | |
| US8278101B2 (en) | Stem cell bioprocessing and cell expansion | |
| CN108384755A (zh) | 一种高效、快捷的诱导性多能干细胞向神经干细胞分化的方法 | |
| CN105420193B (zh) | 分化培养基及其在制备神经干细胞中的用途 | |
| KR20090028104A (ko) | 저 산소 배양액 조건을 이용한 배아 줄기 세포로부터유래된 배상체로부터 혈관 내피 전구 세포의 분화방법 | |
| CN116376822A (zh) | 利用人多潜能干细胞体外制备t淋巴细胞 | |
| Qin et al. | Anti-glioma response of autologous T cells stimulated by autologous dendritic cells electrofused with CD133+ or CD133− glioma cells | |
| CN117683713A (zh) | 利用人多潜能干细胞体外制备t淋巴细胞和nk细胞 | |
| CA2599430A1 (en) | Method of obtaining a population of human haemopoietic stem cells | |
| CN108277203B (zh) | 一种体外维持人造血干祖细胞干性的培养基及方法 | |
| EP3875580A1 (en) | Methods for preparing keratinocytes | |
| CN120442545B (zh) | 一种用于脑类器官分化的基质胶及其制备方法和应用 | |
| EP3875581A1 (en) | Automated method for preparing keratinocytes | |
| Mackowski | Fetal liver hematopoiesis: characterization of the hematopoietic stromal compartment that sustains stem cell expansion | |
| AU2023322418A1 (en) | Extracellular matrix substitute in a cellular microcompartment | |
| Cheng et al. | In vitro Haematopoietic differentiation from pluripotent stem cells or by direct lineage conversion: current advances and challenges | |
| Obrtlíková | Differentiation of Human Embryonic Stem Cells into Endothelial and Smooth Muscle Cells as a Model for Vascular Development | |
| HK1218927B (en) | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20131204 |